Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3256_Библиотеки_им_академика_М_И_Перельмана
.pdf
71
1) ECG stress test with exercise;
2) stress echocardiogram with exercise or using dobutamine or
a vasodilator;
3) exercise or vasodilator positron emission computed tomogra-
phy;
4) magnetic resonance imaging (MRI) of the heart with dobuta-
mine and vasodilator;
5) Hybrid imaging (single-photon emission computed tomogra-
phy) of the heart.
Non-invasive methods of assessing the anatomy of the coronary
arteries
Computed tomography of the coronary arteries is performed
without the introduction of contrast medium or after intravenous ad-
ministration of iodine-containing contrast.
Invasive coronary angiography
Invasive coronary angiography is performed to determine the fea-
sibility of revascularization.
3. What is the treatment tactics?
1. Identication and treatment of concomitant diseases that can
provoke or worsen the course of ischemic heart disease.
2. Lifestyle changes, correction of risk factors.
3. To give up smoking.
4. Blood pressure control. The goal is to lower blood pressure
<140/90 mm Hg. Art. or BP <140/85 mm Hg. Art. with Chronic kid-
ney disease or diabetes mellitus, in patients> 80 years old <150/80
mm Hg. Art.
If a patient with coronary artery disease has dyslipidemia, this
signicantly increases the risk of death, and in such cases, correction
of the blood lipid spectrum should be carried out more vigorously than
in people without signs of coronary artery disease, achieving a de-
crease in total cholesterol levels below 5.2 mmol / L, LDL <1.8 mmol
/ L, triglycerides <1.7 mmol / L.
Stopping an attack of stable angina pectoris:
1) stop physical activity;
2) take a sitting position with lowered legs;
t.me/medicina_free

72
3) take 1 nitroglycerin tablet sublingually (500 mcg) or 1-2 doses
(1.25-2.5 mg) of isosorbide dinitrate aerosol;
4) if ineective, repeat nitroglycerin intake every 5 minutes until
a maximum dose of 1.2 mg is reached for 15 minutes. If there is no
eect from 3 tablets, it is necessary to arrange a call to a doctor or an
ambulance team.
Medication. Three classes of drugs are used: nitrates, β-blockers,
and calcium antagonists. The goal of antianginal therapy is to reduce
myocardial oxygen demand and / or increase myocardial perfusion.
Low-dose aspirin is recommended for all patients with stable coronary
artery disease. Clopidagrel is recommended as an alternative drug in
cases of aspirin intolerance. Statins are recommended for all patients
with stable coronary artery disease. Angiotensin-converting enzyme
inhibitors or angiotensin II receptor blockers are indicated in the pres-
ence of heart failure, arterial hypertension and diabetes mellitus.
Other anti-ischemic drugs (Ivabradine. The initial dose is 5 mg
2 times a day. Nicorandil. It is used in a dose of 20 mg 2 times a day
Trimetazidine It is used in a dose of 35 mg 2 times a day Ranolosin
Starts 500 mg 2 times a day Allopurinol It is used in tablets 600 mg
a day Molsidomin It is used 8 mg 2 times a day { {1}} Lipid-lowering
therapy
All patients, in the absence of contraindications, should be pre-
scribed statins.
If the target level of LDL cholesterol is not achieved, combination
therapy of a statin with ezetimibe is necessary. LDL apheresis or new
lipid-lowering drugs (PCSK9 inhibitors).
4. Medical and labor expertise. Dispensary observation.
Temporary disability. Angina pectoris: rst-onset 10–12
days; stress II FC - 10-15 days; III FC - 20-30 days; IV FC - up to
3–3.5 months; unstable angina pectoris - 25-30 days, acute coronary
insuciency - 40-50 days. MI - small focal without complications 60–
80 days, with complications 3–3.5 months, large focal - 4–5 months.
СН I Art. - 14-21 days, II Art. - 28-42 days, III Art. - 90-120 days.
Heart rhythm disturbances - high-grade ventricular extrasystoles for
t.me/medicina_free

73
7-10 days; complete atrioventricular block with an attack of Morgag-
ni - Adams - Stokes 14–20 days; incomplete atrioventricular block II
stage. 7-10 days; paroxysmal supraventricular tachycardia 5-10 days;
paroxysm of atrial brillation (utter) of the atria 7-10 days; implanta-
tion of pacemaker - 2 months.
Contraindicated types and working conditions. Work associated
with constant or episodic signicant physical (the energy intensity of
the pile is more than 4-5 kcal / min) and neuropsychic stress; stay at
altitude; exposure to vascular and neurotropic poisons; in unfavorable
microclimatic and extreme conditions. Absolutely contraindicated for
patients with pacemaker is work associated with a forced position of
the body, the prescribed pace; exposure to strong static charges, mag-
netic and microwave elds, exposure to electrolytes, strong induction
of thermal and light radiation from stoves and radiators: pronounced
general and local vibration, as well as potential danger to others and
the for the occurred violations of the EKS.
Permanent disability. Indications for referral to the MSEC bu-
reau: Angina pectoris III and IV FC; severe dysfunctions of the car-
diovascular system after MI; severe and moderate heart rhythm dis-
turbances, taking into account the underlying disease that caused their
occurrence, the patient’s absolute dependence on the pacemaker; SN
II, III Art., The presence of contraindications in the nature and condi-
tions of work.
III group of disability is established in connection with the limi-
tation of the ability to self-service, movement, work activity I Art.
in the following cases: exertional angina II (less often - III) FC, CH
I or II A st. (II FC according to NYHA); transferred small or large-
focal myocardial infarction without severe complications in the acute
and subacute stages, or the development in the acute period of tran-
sient atrioventricular blockade, extrasystole not higher than grade 3,
HF I st. by Killip, natural ECG dynamics; completion of an eective
phased rehabilitation program; moderate deviations in ECG monitor-
ing in conditions of everyday activity, mild NDS; moderate decrease
in exercise tolerance (75 W / min) and coronary reserve according to
VEM; a moderate increase in the size of the heart cavities in systole
t.me/medicina_free

74
and diastole according to echocardiography, moderate disorders of the
general (EF 45%) and regional (papillary muscle dysfunction, limited
zones of LV myocardial hypokinesia).After the pacemaker implanta-
tion and the stable course of the underlying disease, the patients are
recognized as invalids of the III group in the case of HF II – III ac-
cording to NYHA, cardiophobic reaction, angina pectoris II FC, the
development of a pacemaker syndrome with moderate dysfunctions
of the cardiovascular and central nervous system. Patients have a need
to limit the amount of work in their previous profession or a loss of
professional suitability due to the eect on the body of pronounced
physical stress, unfavorable microclimatic conditions while maintain-
ing the ability to learn to acquire an uncontradicted profession.
II group of disability is established in connection with the limita-
tion of the ability to self-service, movement, work II Art. in the fol-
lowing cases: angina pectoris III FC, postponed large-focal (transmu-
ral) MI with severe complications in the acute and subacute stages
(paroxysmal tachycardia, atrioventricular block II stage - III stage,
extrasystole of high gradations, heart failure II – III class according
to Killip, acute aneurysm of the heart, pericarditis, etc.), delayed ECG
dynamics, signicantly pronounced deviations in monitoring the ECG
in conditions of daily everyday activity; NDS of medium degree;
marked decrease in exercise tolerance (50 W / min) and coronary re-
serve, according to VEM; a signicant increase in heart cavities in
systole and diastole by echocardiography, a pronounced violation of
the total (EF 35%) and regional (dysfunction of papillary.
Clinical case No. 2
1. Formulate a preliminary diagnosis. Coronary heart disease:
acute Q-myocardial infarction in the region of the lower wall. The
diagnosis was made on the basis of complaints of pain in the epigas-
tric region, accompanied by weakness, sweating, nausea; anamnesis
data: after taking Nitroglycerin under the tongue, the pain decreased;
the data of clinical and laboratory research: on the taken ECG, a deep
Q wave was revealed in the III and aVF leads; the ST segment in the
t.me/medicina_free

75
same leads is raised above the isoline, arcuate, turns into a negative
T wave.
2. Assign additional research methods.
Basic examination in patients with coronary artery disease in-
cludes standard biochemical tests: troponin T or I, complete blood
count with hemoglobin and leukocyte counts, glycated hemoglobin
and fasting plasma glucose, serum creatinine levels, and assessment
of renal function by creatinine clearance , blood lipid spectrum, as-
sessment of thyroid function, hepatic function tests, creatinine phos-
phokinase level, brain natriuretic peptide type B (BNP) or GC-B level,
peptide hormone and its precursor (BNP / NT-proBNP).
Instrumental studies
Electrocardiogram (ECG) at rest and / or during or immediately
after an attack of chest pain, outpatient ECG monitoring (in patients
with suspected arrhythmia and vasospastic angina), echocardiography
at rest to identify violations of regional contractility, determination
of ejection fractions and assessment of diastolic function of the left
ventricle, ultrasound examination of sleep arteries to determine the
thickness of the intima media and / or the detection of atherosclerotic
plaques, chest x-ray.
Studies according to indications
Non-invasive methods for the diagnosis of ischemia:
1) ECG stress test with exercise;
2) stress echocardiogram with exercise or using dobutamine or
a vasodilator;
3) Exercise or vasodilator positron emission computed tomogra-
phy;
4) magnetic resonance imaging (MRI) of the heart with dobuta-
mine and vasodilator;
5) Hybrid imaging (single-photon emission computed tomogra-
phy) of the heart.
Non-invasive methods for assessing the anatomy of the coronary
arteries
t.me/medicina_free

76
Computed tomography of the coronary arteries is performed
without the introduction of a contrast agent or after intravenous ad-
ministration of iodine-containing contrast.
Invasive coronary angiography
Invasive coronary angiography is performed to determine if.
3. What is the treatment tactics?
There are mainly three classes of drugs used: nitrates, β-blockers
and calcium antagonists. The goal of antianginal therapy is to reduce
myocardial oxygen demand and / or increase myocardial perfusion.
Low-dose aspirin is recommended for all patients with stable coronary
artery disease. Clopidagrel is recommended as an alternative drug in
cases of aspirin intolerance. Statins are recommended for all patients
with stable coronary artery disease. Angiotensin-converting enzyme
inhibitors or angiotensin II receptor blockers are indicated in the pres-
ence of heart failure, arterial hypertension and diabetes mellitus.
In some patients with stable angina, one sublingual nitroglyc-
erin is sucient, but if attacks occur more than 2-3 times a week,
a β-blocker or calcium antagonist is added. If the attacks continue af-
ter that, add prolonged nitrates. If necessary, use all three groups of
drugs (nitrates, β-blockers and calcium antagonists).
In combination therapy, the characteristics of each drug should
be taken into account. The combination of dihydroperidine calcium
antagonists (nifedipine) and prolonged nitrates (β-blockers) is not an
optimal combination, since both groups of drugs have a vasodilatory
eect. In patients with severe left ventricular dysfunction, sinus bra-
dycardia, atrioventricular conduction disorders, combination therapy
with β-blockers and calcium antagonists should be used cautiously or
not at all.
The combination of prolonged nitrates with calcium antagonists of
the dehydroperidine series is optimal in the treatment of patients with
atrioventricular conduction disorders. When combining β-blockers,
especially large doses, with calcium antagonists, their negative inotro-
pic eect should be taken into account.
t.me/medicina_free

77
When choosing β-blockers or calcium antagonists as the rst
drug, their clinical features should be guided.
Calcium antagonists should be preferred in the presence of certain
concomitant conditions:
1) obstructive pulmonary disease;
2) sinus bradycardia and severe atrioventricular conduction dis-
orders;
3) variant angina pectoris - Prinzmetal’s angina;
4) severe peripheral arterial disease.
Lipid-lowering therapy
All patients, in the absence of contraindications, should be pre-
scribed statins, with hyperglyceridemia - fenobrate or omega-3 poly-
unsaturated fatty acids. Fenobrate is prescribed at 250-500 mg per
day, omega-3-polyunsaturated fatty acids - 1-2 g per day.
If the target level of LDL cholesterol is not achieved, a combina-
tion therapy of a statin with ezetimibe is required. In the absence of the
eect of combination therapy, it is advisable to include LDL-apheresis
in therapy or prescribe new lipid-lowering drugs (PCSK9 inhibitors).
4. Medical and labor expertise. Dispensary observation. Ex-
amination of the ability to work. If myocardial infarction is not Q-
forming and uncomplicated (angina pectoris not more than I and
Chronic heart failure not more than I stage), employment is indicated
by a clinical expert commission. If MI is complicated (angina pectoris
not more than II and Chronic heart failure not more than II stage) -
also employment on the recommendation of the clinical expert com-
mission, in case of loss of qualications, send to the Medical Social
Expert Commission to determine the disability group. If myocardial
infarction is Q-forming uncomplicated (angina pectoris no more than
I and Chronic heart failure no more than stage I), then persons of phys-
ical labor and / or a greater volume of industrial activity should be sent
to the Medical and Social Expert Commission
to establish a disability group. If myocardial infarction is com-
plicated (angina pectoris more than I-II and Chronic heart failure no
t.me/medicina_free

78
more than stage II), then regardless of the specialty, patients are also
sent to the Medical and Social Expert Commission to establish a group
of disability. Spa treatment. After suering an MI more than 1 year
ago without attacks of angina pectoris or with rare bouts of tension
without disturbing the rhythm and signs of Heart Failure of no more
than 1 FC, treatment is possible both in local cardiological sanatori-
ums and in distant climatic resorts (excluding mountain resorts). With
a higher FC of angina pectoris and Heart Failure, treatment is indi-
cated only in local sanatoriums.
Prevention. The main therapeutic and recreational activities: rec-
ommendations for a healthy lifestyle. Hardening procedures. Reme-
diation of foci of chronic infection. Patients are under the supervision
of a cardiologist, in his absence - by a local doctor.
Clinical case No. 3
1. Formulate a preliminary diagnosis. Coronary heart disease:
myocardial infarction.
2. Assign additional research methods
Basic examination in patients with coronary artery disease in-
cludes standard biochemical tests: troponin T or I level, complete
blood count with hemoglobin and leukocyte counts, glycated hemo-
globin and fasting plasma glucose, serum creatinine level and assess-
ment of renal function by creatinine clearance, blood lipid spectrum,
assessment of thyroid function, hepatic function tests, creatinine phos-
phokinase level, brain natriuretic peptide type B (BNP) or GC-B level,
peptide hormone and its precursor (BNP / NT-proBNP).
Instrumental studies
Electrocardiogram (ECG) at rest and / or during or immediately
after an attack of chest pain, outpatient ECG monitoring (in patients
with suspected arrhythmia and vasospastic angina ), echocardiography
at rest to identify violations of regional contractility, determination of
ejection fractions and assessment of diastolic function ventricle, ultra-
sound examination of the carotid arteries to determine the thickness of
t.me/medicina_free

79
the intima media and / or detection of atherosclerotic plaques, chest
x-ray.
Studies according to indications
Non-invasive methods for the diagnosis of ischemia: 1) ECG
stress test with exercise;
2) stress echocardiogram with exercise or using dobutamine or
a vasodilator;
3) exercise or vasodilator positron emission computed tomogra-
phy;
4) magnetic resonance imaging (MRI) of the heart with dobuta-
mine and vasodilator;
5) Hybrid imaging (single-photon emission computed tomogra-
phy) of the heart.
Non-invasive methods of assessing the anatomy of the coronary
arteries
Computed tomography of the coronary arteries is performed
without the introduction of contrast medium or after intravenous ad-
ministration of iodine-containing contrast.
Invasive coronary angiography
Invasive coronary angiography is performed to determine if.
3. What is the treatment tactics?
Treatment plan: relief of pain syndrome - narcotic analgesics,
antipsychotics, brinolytic and anticoagulant therapy, prevention of
rhythm disturbances, treatment of complications.
There are mainly three classes of drugs used: nitrates, β-blockers
and calcium antagonists. The goal of antianginal therapy is to reduce
myocardial oxygen demand and / or increase myocardial perfusion.
Low-dose aspirin is recommended for all patients with stable coronary
artery disease. Clopidagrel is recommended as an alternative drug in
cases of aspirin intolerance. Statins are recommended for all patients
with stable coronary artery disease. Angiotensin-converting enzyme
inhibitors or angiotensin II receptor blockers are indicated in the pres-
ence of heart failure, arterial hypertension and diabetes mellitus.
t.me/medicina_free

80
In combination therapy, the characteristics of each drug should
be taken into account. The combination of dihydroperidine calcium
antagonists (nifedipine) and prolonged nitrates (β-blockers) is not an
optimal combination, since both groups of drugs have a vasodilatory
eect. In patients with severe left ventricular dysfunction, sinus bra-
dycardia, atrioventricular conduction disorders, combination therapy
with β-blockers and calcium antagonists should be used with caution
or not at all.
The combination of prolonged nitrates with calcium antagonists of
the dehydroperidine series is optimal in the treatment of patients with
disorders atrioventricular conduction. When combining β-blockers,
especially large doses, with calcium antagonists, their negative inotro-
pic eect should be taken into account.
When choosing β-blockers or calcium antagonists as the rst
drug, their clinical features should be guided.
Calcium antagonists should be preferred in the presence of certain
concomitant conditions:
1) obstructive pulmonary disease;
2) sinus bradycardia and severe atrioventricular conduction dis-
orders;
3) variant angina pectoris - Prinzmetal’s angina;
4) severe peripheral arterial disease.
Lipid-lowering therapy
All patients, in the absence of contraindications, should be pre-
scribed statins, with hyperglyceridemia - fenobrate or omega-3 poly-
unsaturated fatty acids. Fenobrate is prescribed at 250-500 mg per
day, omega-3-polyunsaturated fatty acids - 1-2 g per day.
If the target level of LDL cholesterol is not achieved, a combina-
tion therapy of a statin with ezetimibe is required. In the absence of the
eect of combination therapy, it is advisable to include LDL-apheresis
in therapy or prescribe new lipid-lowering drugs (PCSK9 inhibitors).
4. Medical and labor expertise. Dispensary observation. Ex-
amination of the ability to work. If myocardial infarction is not Q-
forming and uncomplicated (angina pectoris not more than I and
t.me/medicina_free
Соседние файлы в папке Библиотека им академика М.И. Перельмана
